RHJA
Rice Hall James & Associates’s Pacira BioSciences PCRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6.22M | Buy |
260,287
+2,779
| +1% | +$66.4K | 0.34% | 72 |
|
|
2025
Q1 | $6.4M | Sell |
257,508
-2,677
| -1% | -$66.5K | 0.38% | 65 |
|
|
2024
Q4 | $4.9M | Sell |
260,185
-8,152
| -3% | -$154K | 0.27% | 81 |
|
|
2024
Q3 | $4.04M | Sell |
268,337
-730,288
| -73% | -$11M | 0.22% | 101 |
|
|
2024
Q2 | $28.6M | Sell |
998,625
-44,915
| -4% | -$1.29M | 1.71% | 13 |
|
|
2024
Q1 | $30.5M | Buy |
1,043,540
+7,571
| +0.7% | +$221K | 1.74% | 14 |
|
|
2023
Q4 | $35M | Buy |
1,035,969
+67,484
| +7% | +$2.28M | 2.02% | 10 |
|
|
2023
Q3 | $29.7M | Buy |
968,485
+61,680
| +7% | +$1.89M | 1.89% | 11 |
|
|
2023
Q2 | $36.3M | Buy |
906,805
+163,209
| +22% | +$6.54M | 2.06% | 8 |
|
|
2023
Q1 | $30.3M | Buy |
743,596
+306,311
| +70% | +$12.5M | 1.72% | 11 |
|
|
2022
Q4 | $16.9M | Buy |
437,285
+29,407
| +7% | +$1.14M | 0.97% | 31 |
|
|
2022
Q3 | $21.7M | Sell |
407,878
-16,202
| -4% | -$862K | 1.26% | 22 |
|
|
2022
Q2 | $24.7M | Sell |
424,080
-32,718
| -7% | -$1.91M | 1.2% | 23 |
|
|
2022
Q1 | $34.9M | Buy |
456,798
+36,593
| +9% | +$2.79M | 1.39% | 18 |
|
|
2021
Q4 | $25.3M | Buy |
420,205
+86,256
| +26% | +$5.19M | 0.9% | 34 |
|
|
2021
Q3 | $18.7M | Buy |
333,949
+3,466
| +1% | +$194K | 0.69% | 46 |
|
|
2021
Q2 | $20.1M | Sell |
330,483
-219,113
| -40% | -$13.3M | 0.71% | 48 |
|
|
2021
Q1 | $38.5M | Sell |
549,596
-4,338
| -0.8% | -$304K | 1.26% | 26 |
|
|
2020
Q4 | $33.1M | Sell |
553,934
-19,474
| -3% | -$1.17M | 1.17% | 27 |
|
|
2020
Q3 | $34.5M | Sell |
573,408
-40,207
| -7% | -$2.42M | 1.39% | 21 |
|
|
2020
Q2 | $32.2M | Sell |
613,615
-14,099
| -2% | -$740K | 1.38% | 23 |
|
|
2020
Q1 | $21M | Buy |
627,714
+210,863
| +51% | +$7.07M | 1.18% | 24 |
|
|
2019
Q4 | $18.9M | Sell |
416,851
-11,609
| -3% | -$526K | 0.64% | 55 |
|
|
2019
Q3 | $16.3M | Sell |
428,460
-8,067
| -2% | -$307K | 0.58% | 62 |
|
|
2019
Q2 | $19M | Sell |
436,527
-27,513
| -6% | -$1.2M | 0.63% | 53 |
|
|
2019
Q1 | $17.7M | Buy |
464,040
+12,213
| +3% | +$465K | 0.57% | 61 |
|
|
2018
Q4 | $19.4M | Buy |
451,827
+122,569
| +37% | +$5.27M | 0.71% | 41 |
|
|
2018
Q3 | $16.2M | Sell |
329,258
-8,774
| -3% | -$431K | 0.58% | 70 |
|
|
2018
Q2 | $10.8M | Buy |
338,032
+12,161
| +4% | +$390K | 0.39% | 88 |
|
|
2018
Q1 | $10.2M | Buy |
325,871
+2,102
| +0.6% | +$65.5K | 0.4% | 92 |
|
|
2017
Q4 | $14.8M | Buy |
323,769
+50,335
| +18% | +$2.3M | 0.58% | 73 |
|
|
2017
Q3 | $10.3M | Buy |
273,434
+79,797
| +41% | +$3M | 0.45% | 85 |
|
|
2017
Q2 | $9.24M | Buy |
193,637
+66,444
| +52% | +$3.17M | 0.4% | 92 |
|
|
2017
Q1 | $5.8M | Buy |
127,193
+4,298
| +3% | +$196K | 0.28% | 98 |
|
|
2016
Q4 | $3.97M | Buy |
122,895
+20,290
| +20% | +$655K | 0.2% | 101 |
|
|
2016
Q3 | $3.51M | Buy |
102,605
+28,904
| +39% | +$989K | 0.18% | 107 |
|
|
2016
Q2 | $2.49M | Buy |
73,701
+2,143
| +3% | +$72.3K | 0.14% | 131 |
|
|
2016
Q1 | $3.79M | Buy |
71,558
+1,674
| +2% | +$88.7K | 0.22% | 99 |
|
|
2015
Q4 | $5.37M | Buy |
69,884
+29,602
| +73% | +$2.27M | 0.31% | 88 |
|
|
2015
Q3 | $1.66M | Buy |
40,282
+3,326
| +9% | +$137K | 0.11% | 190 |
|
|
2015
Q2 | $2.61M | Buy |
+36,956
| New | +$2.61M | 0.15% | 148 |
|